Viewing Study NCT03288350

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-01-22 @ 6:16 AM
Study NCT ID: NCT03288350
Status: UNKNOWN
Last Update Posted: 2018-03-22
First Post: 2017-09-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: mDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma View
None Esophageal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase II Trial View
None Esophago-Gastric Adenocarcinoma View
None Avelumab View